Stay updated with breaking news from Technology Analytics Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IQVIA (NYSE:IQV – Get Free Report) had its price objective decreased by equities researchers at Evercore ISI from $275.00 to $250.00 in a report released on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the medical research company’s stock. Evercore ISI’s price target would suggest a potential upside of 11.91% from the […]
Natixis Advisors L.P. lifted its position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 12.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 168,910 shares of the medical research company’s stock after purchasing an additional 18,469 shares during […]
Natixis Advisors L.P. increased its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 12.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 168,910 shares of the medical research company’s stock after buying an additional 18,469 shares during the […]
IQVIA Holdings Inc. ("IQVIA") , a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2024....
Berry Wealth Group LP purchased a new stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,297 shares of the medical research company’s stock, valued at approximately $531,000. Several other large investors have […]